The different isoforms of the receptor for advanced glycation endproducts as key points in the septic immune response

The different isoforms of the receptor for advanced glycation endproducts as key points in the septic immune response - RAMMSES-Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00000505

Enrollment

120

Registered

2010-11-08

Start date

2009-08-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A41.9

Interventions

Group 1: Patients with septic shock Group 2: Patients following major abdominal surgery Group 3: Healthy volunteers

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Sepsis criteria according to international guidelines

Exclusion criteria

Exclusion criteria: Not meeting the inclusion criteria - Refusing study participation - Pre-existing renal disease - Rheumatoid arthritis - M. Alzheimer - Inflammatory bowel disease - Chronic pancreatitis - Arteriosclerosis with preceding myocardial ischemia

Design outcomes

Primary

Measure	Time frame
Survival	—

Secondary

Measure	Time frame
Disease Severity	—

Countries

Germany

Contacts

Public ContactStefan Hofer

Klinik für Anaesthesie Uniklinkum Heidelberg

stefan.hofer@med.uni-heidelberg.de06221 5637787

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 7, 2026